News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Hikma Pharmaceuticals - Preliminary Results Presentation
March 22, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Live analyst presentation on www.cantos.com at 0930GMT with Samih Darwazah, CEO, and Bassam Kannan, CFO (LSE: HIK)
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
Charles River, Thermo Fisher Lay Off Staff Amid Site Closures
February 6, 2026
·
51 min read
·
BioSpace Editorial Staff
GLP-1
Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill
February 6, 2026
·
1 min read
·
Tristan Manalac
Editorial
Novo Will Never Beat Lilly. Why Does It Have To?
February 5, 2026
·
3 min read
·
Annalee Armstrong
Earnings
BMS Beats Again Despite Eliquis and Cobenfy Disappointments
February 5, 2026
·
2 min read
·
Dan Samorodnitsky
